Quick Answer: GLP-1 receptor agonists are being investigated for potential neuroprotective effects in Alzheimer's disease, but they are not FDA-approved for dementia prevention or treatment
Full article here: To view or add a comment, sign in Around the world, millions of people who live with #obesity are at the point in their weight loss journey where, after successfully accessing and using prescription weight loss medications such as Wegovy or Mounjaro and having reached their initial weight loss goal, ask: what's next
Any products and informational content displayed on this page are not intended to diagnose, treat, cure, or prevent any disease.
Align with Your Preferences GLP-1 agonists: If you prefer a less invasive, gradual approach and can commit to regular injections or pills, GLP-1 agonists might be better
Front Endocrinol (Lausanne) (2014) 5:110